Singapore markets closed

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.28-0.94 (-3.33%)
As of 11:11AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
6,414
0
203,196
117,912
94,387
Cost of revenue
-
-
2,805
1,317
1,397
Gross profit
-
-
200,391
116,595
92,990
Operating expenses
Research development
281,945
256,973
367,470
410,894
341,324
Selling general and administrative
118,459
121,445
149,070
132,034
114,145
Total operating expenses
400,404
378,418
516,540
542,928
455,469
Operating income or loss
-394,764
-378,418
-316,149
-426,333
-362,479
Interest expense
-
-
17,832
-
-
Total other income/expenses net
22,266
21,072
-
-
-
Income before tax
-369,423
-356,510
-327,370
-411,472
-346,028
Income from continuing operations
-369,423
-356,510
-327,370
-411,472
-346,028
Net income
-369,973
1,604,715
-327,370
-411,472
-346,028
Net income available to common shareholders
-369,973
1,604,715
-327,370
-411,472
-346,028
Basic EPS
-
26.55
-4.74
-6.86
-6.03
Diluted EPS
-
26.55
-4.74
-6.86
-6.03
Basic average shares
-
60,447
68,998
59,995
57,418
Diluted average shares
-
60,447
68,998
59,995
57,418
EBITDA
-
-369,178
-299,554
-418,246
-355,307